Quantitative and functional analysis of PDC‐E2‐specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
While the pathologic mechanisms responsible for organ-specific tissue damage in primary biliary cirrhosis (PBC) remain an enigma, it has been suggested that the pathology is mediated by autoreactive T cells infiltrating the intrahepatic bile ducts. Previously, we have documented that there is 100-fold enrichment in the frequency of CD4+ autoreactive T cells in the liver that are specific for peptides encoded by the E2 components of the pyruvate dehydrogenase complexes (PDC-E2). We have also recently characterized the first MHC class I–restricted epitope for PDC-E2, namely amino acid 159–167, a region very similar to the epitope recognized by MHC class II–restricted CD4+ cells and by autoantibodies. The effector functions of these PDC-E2159-167–specific CD8+ cytotoxic T lymphocytes (CTLs) are not well understood. We have taken advantage of tetramer technology and report herein that there is tenfold increase in the frequency of PDC-E2159-167–specific CTLs in the liver as compared with the blood in PBC. In addition, the precursor frequency of the CTLs in blood was significantly higher in early-stage PBC. Of interest was the fact that, upon stimulation with the peptide, the response of PDC-E2159-167 tetramer-positive cells is heterogeneous with respect to IFN-γ synthesis. These data, we believe for the first time, document the enrichment of autoantigen-specific CD8+ T cells in the PBC liver, suggesting that CD8+ T cells play a significant role in the immunopathogenesis of PBC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129 · cited 1×
“Dendritic cells (DCs) were generated from PBMCs of HLA-A*0201–positive donors as described (18) and used as antigen-presenting cells (APCs).”
MethodPhenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“PDC-E2159-167-HLA A2 tetramers were generated as described (17).”
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., et al. (1999) · Nature Medicine · doi:10.1038/9525 · Cited by 1,113
Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., & Rickinson, A. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1395 · Cited by 892
Garboczi, D. N., Hung, D. T., & Wiley, D. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3429 · Cited by 689
A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis
Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Öhlén, C., & Goverman, J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.669 · Cited by 659
Separation of IL-4 Production from Th Cell Proliferation by an Altered T Cell Receptor Ligand
Evavold, B. D., & Allen, P. M. (1991) · Science · doi:10.1126/science.1833816 · Cited by 549
Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H. L., & Hafler, D. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.973 · Cited by 529
Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., & Tisch, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3912 · Cited by 456
Cited by
Items 201–223 of 223
Gerussi, A., & Fornai, M. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108144 · Cited by 2
Yamakawa, M., Mitsui, H., Ohtake, H., Ohe, R., & Yamakawa, M. (2013) · Pathology and Laboratory Medicine International · doi:10.2147/plmi.s38078 · Cited by 2
Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis
Nanjundappa, R. H., Kolla, H. B., Edgar, A. J., Leung, P. S. C., Chauhan, D. S., Ridgway, W. M., Gershwin, M. E., & Umeshappa, C. S. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103473 · Cited by 2
Self-citationPrimary Biliary Cholangitis: Its Science and Practice
Wang, L., Bowlus, C. L., Wang, F., & Gershwin, M. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-50168-0_8 · Cited by 2
Self-citationGeoepidemiology of Autoimmune Liver Diseases
Lyu, Z., Gershwin, M. E., & Ma, X. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_11 · Cited by 1
Self-citationThe Onset Mechanism of Primary Biliary Cirrhosis
Shimoda, S. (2014) · Springer eBooks · doi:10.1007/978-4-431-54789-1_12 · Cited by 2
Tanaka, A., & Gershwin, M. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00058-0 · Cited by 2
Self-citationHuang, W., Jiang, R., Zeng, R., Ma, Y., Zhang, L., Tong, S., Lyu, Y., Wang, J., Leung, F. W., Sha, W., et al. (2023) · medRxiv · doi:10.1101/2023.03.01.23286611 · Cited by 1
Chapter 12 Primary Biliary Cirrhosis
Abdalian, R., & Heathcote, J. (2008) · Technical report · doi:10.1016/s1571-5078(07)00012-8
Xenobiotic Induced Model of Primary Biliary Cirrhosis
Arsenijević, A., Milovanović, J., Stojanović, B., Milovanović, M., Gershwin, E. M., Leung, P. S. C., Arsenijević, N., & Lukić, M. L. (2014) · Serbian Journal of Experimental and Clinical Research · doi:10.2478/sjecr-2014-0019 · Cited by 2
Pathogenic mechanism of primary biliary cirrhosis
Shimoda, S., Nakamura, M., & Ishibashi, H. (2013) · Kanzo · doi:10.2957/kanzo.54.676
Cholestatic liver diseases: primary biliary cirrhosis
Thimme, R., OPITZ, O. G., & Kreisel, W. (2002) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2002-33861 · Cited by 3
Abdalian, R., Heathcote, J., & Ramos‐Casals, M. (2017) · Technical report · doi:10.1016/b978-0-444-63707-9.00005-2
Jones, D. E. (2018) · Wiley eBooks · doi:10.1002/9781119237662.ch17 · Cited by 1
Menacho, J. E. O., & Candela, J. A. O. (2020) · Revista Médica Herediana · doi:10.20453/rmh.v31i2.3770 · Cited by 1
Leung, P. S. C., Manns, M. P., Coppel, R. L., & Gershwin, M. E. (2006) · Wiley eBooks · doi:10.1128/9781555815905.ch122
Self-citationKhakoo, N. S., & Levy, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00039-4
The Adaptive Immune System and Liver Toxicity
Holt, M. R., & Ju, C. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01030-7
Yang, M., Ren, H., Ren, X., Wen, P., Xie, J., Wan, X., Xu, K., Liu, L., Hou, W., Yang, Z., et al. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10224-5
Influence of bile acids metabolism on hepatic immunity in mice
Guinot, V. (2022) · theses.fr (ABES) · doi:10.70675/b69bb11eza30fz4874z9af2za6e31b2d5ad8
Can we cure primary biliary cholangitis?
Trivedi, P. J., Hirschfield, G. M., & Gershwin, M. E. (2026) · Current Opinion in Immunology · doi:10.1016/j.coi.2026.102786
Self-citationInfection, Autoimmunity and Autoimmune Liver Diseases
He, X.-S., & Gershwin, M. E. (2004) · Elsevier eBooks · doi:10.1016/b978-044451271-0.50042-9
Self-citation
Metadata
- Authors
- Kita, H., Matsumura, S., He, X.-S., Ansari, A. A., Lian, Z.-X., Van de Water, J., Coppel, R. L., Kaplan, M. M., & Gershwin, M. E.
- Affiliations
- University of California, Davis (US)
- Emory University (US)
- Monash University (AU)
- Tufts Medical Center (US)
- Corresponding author
- Gershwin, M. Eric
- Venue
- Journal of Clinical Investigation
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 9
- Pages
- 1231-1240
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4229877359
- Cited by
- 222
- References
- 38
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 9 · 2021: 10 · 2020: 10 · 2019: 5 · 2018: 7 · 2017: 9 · 2016: 6 · 2015: 10 · 2014: 11 · 2013: 12 · 2012: 6
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- primary biliary cirrhosis, PDC-E2, pyruvate dehydrogenase complex, CD8+ T cells, MHC class I epitopes, immunopathogenesis, interferon-gamma, autoantigen-specific T cells, CD4+ T cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.